English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Few areas of medical practice and history generate such lively discussion as the continuing relevance and appropriateness of eponyms.1,2 Given controversies of unethical practice by physicians associated with some eponyms,3 misattribution of the original description4 and the transformation of progression in medical research from the model of the inspired solo practitioner to that of interdisciplinary team work, it is likely that few future physicians will generate a widely adopted eponym.In recent times, a different form of eponym has evolved whereby wider awareness and appreciation of relatively neglected illnesses has occurred through identification with a famous person affected by the illness. The cause, and popular understanding, of motor neuron disease in North America was considerably supported by the adoption of the title Lou Gehrig disease, after the famous baseball player.5 In a similar fashion, public awareness of adrenoleukodystrophy was increased by its association with Lorenzo’s oil, a potential therapy named after a patient.6Could chronic stroke disease, a complex illness with huge societal impact, benefit in a similar way from identification with a famous sufferer? Although stroke has been relatively neglected in terms of research funding and clinical development,7 the welcome focus in the last two decades on acute and hyperacute care—stroke units and thrombolysis—may divert attention from the wider and more chronic manifestations of stroke disease.8 These include dementia,9 gait disorders,10 depression11 and oropharyngeal dysphagia,12 a combination of which may occur in a single person. The recognition of these stroke syndromes is important at many levels: they represent an important target for primary and secondary prevention,13 as well as opportunities for better assessment, treatment and management. Yet even in major international conferences in stroke, these conditions merit scant attention, and knowledge among the general public …

Stravinsky syndrome: giving a voice to chronic stroke disease